Cytosorbents (CTSO) Depreciation and Depletion (2024 - 2026)
Cytosorbents (CTSO) posted Depreciation and Depletion of $300000.0 for Q1 2026, little changed on a QoQ basis from $300000.0 in Q4 2025, and down 1.96% year-over-year from $306000.0 in Q1 2025.
Cytosorbents (CTSO) Depreciation and Depletion (2024 - 2026) Analysis & Trends
Cytosorbents' Depreciation and Depletion history runs 3 years deep, the most recent figure standing at $300000.0 for Q1 2026.
- Quarterly Depreciation and Depletion fell 1.96% year-over-year to $300000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 12.45% YoY) and the FY2025 annual result came in at $1.2 million, down 7.69% from the prior year.
- Depreciation and Depletion was $300000.0 for Q1 2026 at Cytosorbents, roughly flat from $300000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $457800.0 in Q2 2024 and bottomed at $294000.0 in Q2 2025.
- A 3-year average of $322222.2 and a median of $300000.0 in 2024 frame the typical range for Depreciation and Depletion.
- Peak annual rise in Depreciation and Depletion reached 0.0% in 2025, while the deepest fall reached 35.78% in 2025.
- Cytosorbents' Depreciation and Depletion stood at $300000.0 in 2024, then changed by 0.0% to $300000.0 in 2025, then changed by 0.0% to $300000.0 in 2026.
- Business Quant data shows CTSO's Depreciation and Depletion at $300000.0 in Q1 2026, $300000.0 in Q4 2025, and $300000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 308.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 89.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 300,000.00 |
| Dec 31, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 294,000.00 |
| Jun 30, 2025 | 294,000.00 |
| Mar 31, 2025 | 306,000.00 |
| Mar 31, 2025 | 306,000.00 |
| Dec 31, 2024 | 300,000.00 |
| Dec 31, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 457,800.00 |
| Jun 30, 2024 | 457,800.00 |
| Mar 31, 2024 | 342,200.00 |
| Mar 31, 2024 | 342,200.00 |